Partner
Steve Gullans
Other at InnoCom Bio Equities
- Firm
- InnoCom Bio Equities
- Role
- Other
Record updated 21 September 2026
About
Excel Venture Management, Managing Director Harvard University, Professor Venture investor, board director, executive, entrepreneur, scientist, author. Managed $225M fund invested in more than 40 life science companies. Senior executive, director and/or founder of NASDQ listed Gemphire Therapeutics, Thynk, Orionis Biosciences, iSpecimen, Navigation Sciences, and Alexis Bio, As professor at Harvard Medical School, co-authored 130 scientific papers and served on AAAS and AHA. A TED, TEDMED, and TEDx speaker. Has provided innovation advisory to many companies and academic institutions.
Is this you? Remove my profile